Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated platelet-rich plasma for infertility with diminished ovarian reserve
IRCT20160815029374N7Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous platelet-rich plasma in female infertility, Diminished Ovarian Reserve (DOR) and ovarian hypofunction (POI), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Change in anti-Mullerian hormone level. Started Jan 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)ovarian hypofunction (POI)
Beyond the preview
Go deeper on IRCT20160815029374N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160815029374N7.